US DMFs Filed
USA (Orange Book)
PharmaCompass offers a list of Buprenorphine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Buprenorphine manufacturer or Buprenorphine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Buprenorphine manufacturer or Buprenorphine supplier.
PharmaCompass also assists you with knowing the Buprenorphine API Price utilized in the formulation of products. Buprenorphine API Price is not always fixed or binding as the Buprenorphine Price is obtained through a variety of data sources. The Buprenorphine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Buprenorphine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Buprenorphine, including repackagers and relabelers. The FDA regulates Buprenorphine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Buprenorphine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
CLICK HERE to find a list of Buprenorphine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Buprenorphine supplier is an individual or a company that provides Buprenorphine active pharmaceutical ingredient (API) or Buprenorphine finished formulations upon request. The Buprenorphine suppliers may include Buprenorphine API manufacturers, exporters, distributors and traders.
CLICK HERE to find a list of Buprenorphine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Buprenorphine DMF (Drug Master File) is a document detailing the whole manufacturing process of Buprenorphine active pharmaceutical ingredient (API) in detail. Different forms of Buprenorphine DMFs exist exist since differing nations have different regulations, such as Buprenorphine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Buprenorphine DMF submitted to regulatory agencies in the US is known as a USDMF. Buprenorphine USDMF includes data on Buprenorphine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Buprenorphine USDMF is kept confidential to protect the manufacturer’s intellectual property.
CLICK HERE to find a list of Buprenorphine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Buprenorphine Drug Master File in Japan (Buprenorphine JDMF) empowers Buprenorphine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Buprenorphine JDMF during the approval evaluation for pharmaceutical products. At the time of Buprenorphine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
CLICK HERE to find a list of Buprenorphine suppliers with JDMF on PharmaCompass.
A Buprenorphine CEP of the European Pharmacopoeia monograph is often referred to as a Buprenorphine Certificate of Suitability (COS). The purpose of a Buprenorphine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Buprenorphine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Buprenorphine to their clients by showing that a Buprenorphine CEP has been issued for it. The manufacturer submits a Buprenorphine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Buprenorphine CEP holder for the record. Additionally, the data presented in the Buprenorphine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Buprenorphine DMF.
A Buprenorphine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Buprenorphine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
CLICK HERE to find a list of Buprenorphine suppliers with CEP (COS) on PharmaCompass.
A Buprenorphine written confirmation (Buprenorphine WC) is an official document issued by a regulatory agency to a Buprenorphine manufacturer, verifying that the manufacturing facility of a Buprenorphine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Buprenorphine APIs or Buprenorphine finished pharmaceutical products to another nation, regulatory agencies frequently require a Buprenorphine WC (written confirmation) as part of the regulatory process.
CLICK HERE to find a list of Buprenorphine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Buprenorphine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Buprenorphine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Buprenorphine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Buprenorphine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Buprenorphine NDC to their finished compounded human drug products, they may choose to do so.
CLICK HERE to find a list of Buprenorphine suppliers with NDC on PharmaCompass.
Buprenorphine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Buprenorphine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Buprenorphine GMP manufacturer or Buprenorphine GMP API supplier for your needs.
A Buprenorphine CoA (Certificate of Analysis) is a formal document that attests to Buprenorphine's compliance with Buprenorphine specifications and serves as a tool for batch-level quality control.
Buprenorphine CoA mostly includes findings from lab analyses of a specific batch. For each Buprenorphine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Buprenorphine may be tested according to a variety of international standards, such as European Pharmacopoeia (Buprenorphine EP), Buprenorphine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Buprenorphine USP).